Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques

Neuroscience

Volumn 89, Issue 1, 1999, Pages 267-277

  Pecins Thompson, M ^a,b   Bethea, C L ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

5 HT(1A) autoreceptor; Dorsal raphe; Estrogen; Primate; Progesterone; Serotonin

Indexed keywords

AUTORECEPTOR; COMPLEMENTARY DNA; ESTROGEN; MESSENGER RNA; PROGESTERONE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; FEMALE; HORMONAL REGULATION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RHESUS MONKEY; SEROTONINERGIC NERVE CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; AUTORECEPTORS; CLONING, MOLECULAR; ESTROGENS; FEMALE; IN SITU HYBRIDIZATION; MACACA MULATTA; MOLECULAR SEQUENCE DATA; OVARY; PROGESTERONE; RAPHE NUCLEI; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SYNAPTIC TRANSMISSION;

EID: 0033105944     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00326-1     Document Type: Article

References (62)

1. Albert P. R., Zhou Q., Van Tol H. H., Bunzow J. R. and Civelli O. (1990) Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine IA receptor gene. J. Biol. Chem. 265, 5825-5832.
2. Anderson I. M., Ware C. J., Da Roza Davis J. M. and Cowen P. J. (1992) Decreased 5-HT-mediated prolactin release in major depression. Br. J. Psychiat. 160, 372-378.
3. Anderson I. M. and Cowen P. J. (1992) Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers. Psychopharmacology 106, 428-432.
4. Artigas F., Perez V. and Alvarez E. (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Archs Gen. Psychiat. 51, 248-251.
5. Bethea C. L. (1994) Regulation of progestin receptors in raphe neurons of steroid-treated monkeys. NeuroendocrinOlogy 60, 50-61.
6. Biegon A., Fischette C. T., Rainbow T. C. and McEwen B. S. (1982) Serotonin receptor modulation by estrogen in discrete brain nuclei. Neuroendocrinology 35, 287-291.
7. Biegon A., Reches A., Snyder L. and McEwen B. S. (1983) Serotonergic and noradrenergic receptors in the rat brain: Modulation by chronic exposure to ovarian hormones. Life Sci. 32, 2015-2021.
8. 1A autoreceptors. Neuropharmacology 32, 527-534.
9. Brenner R. M. and Maslar I. A. (1988) The primate oviduct and endometrium. In The Physiology of Reproduction, 1st Edn (eds Knobil E. and Neill J. D.), pp. 303-327. Raven, New York.
10. Brown T., MacLusky N. J., Leranth C., Shanabrough M. and Naftolin F. (1990) Progestin receptor-containing cells in guinea pig hypothalamus: Afferent connections, morphological characteristics, and neurotransmitter content. Molec. Cell. Neurosci. 1, 58-77.
11. Burnet P. W. J., Eastwood S. L., Lacey K. and Harrison P. J. (1995) The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain. Brain Res. 676, 157-168.
12. Chalmers D. T. and Watson S. J. (1991) Comparative anatomical distribution of 5-HT1A receptor mrna and 5-HT1A binding in rat brain - A combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res. 561, 51-60.
13. Clemens J. A. (1975) Neuropharmacological aspects of the neural control of prolactin secretion. In Hypothalamus and Endocrine Functions (eds Labrie F., Meites J. and Pelletier G.), pp. 283-301. Plenum, New York.
14. Coccaro E. F., Gabriel S. and Siever L. J. (1990) Buspirone challenge: Preliminary evidence for a role for central 5-HT1A receptor function in impulsive aggressive behavior in humans. Psychopharmac. Bull. 26, 393-405.
15. De Lignieres B. and Vincens M. (1982) Differential effects of exogenous oestradiol and progesterone on mood in post-menopausal women: Individual dose/effect relationship. Maturitas 4, 67-72.
16. Eriksson E., Hedberg M. A., Andersch B. and Sundblad C. (1995) The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maproltiline in the treatment of premenstrual syndrome. NeuroPsychopharmacology 12, 167-176.
17. Fischette C. T., Biegon A. and McEwen B. S. (1983) Sex differences in serotonin 1 receptor binding in rat brain. Science 222, 333-335.
18. Gitlin M. J. and Pasnau R. O. (1989) Psychiatric syndromes linked to reproductive function in women: A review of current knowledge. Am. J. Psychiat. 146, 1413-1422.
19. Goodwin G. M. (1996) How do antidepressants affect serotonin receptors? the role of serotonin receptors in the therapeutic and side effect profile of the SSRIs. J. Clin. Psychiat. 57, 9-13.
20. Gregoire A. J. P., Kumar R., Everitt B. and Henderson A. F. (1996) Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347, 930-933.
21. Halbreich U. and Tworek H. (1993) Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int. J. Psychiat. Med. 23, 1-27.
22. Hamon M., Fattaccini C.-M., Adrien J., Gallissot M.-C., Martin P. and Gozlan H. (1988) Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine 1A agonists with potential anxiolytic properties. J. Pharmac. Exp. Ther. 246, 745-752.
23. Hery M., Becquet D., Francois-Bellan A., Deprez P., Fache M. and Hery F. (1995) Stimulatory effects of 5-HT1A receptor agonists on luteinizing hormone-releasing hormone release from cultured fetal rat hypothalamic cells: Interactions with progesterone. Neuroendocrinology 61, 11-18.
24. Hillegaart V., Hjorth S. and Ahlenius S. (1990) Effects of 5-HT and 8-OH-DPAT on forebrain monamine synthesis after local application into the median and dorsal raphe nuclei of the rat. J. Neural Transm. 81, 131-145.
25. Hjorth S. and Magnusson T. (1988) The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-schmiedeberg's Arch. Pharmac. 338, 463-471.
26. Hotchkiss J. and Knobil K. (1994) The menstrual cycle and its neuroendocrine control. In The Physiology of Reproduction, 2nd Edn (eds Knobil E. and Neill J. D.), pp. 711-750. Raven, New York.
27. Invernizzi R., Carli M., Di Clemente A. and Samanin R. (1991) Administration of 8-hydroxy-2-(di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in the rat brain: Differences in potency and regional sensitivity. J. Neurochem. 56, 243-247.
28. James M. D., Hole D. R. and Wilson C. A. (1989) Differential involvement of 5-hydroxytryptamine (5-HT) in specific hypothalamic areas in the mediation of steroid-induced changes in gonadotrophin release and sexual behavior in female rats. Neuroendocrinology 49, 561-569.
29. Julius D. (1991) Molecular biology of serotonin receptors. A. Rev. Neurosci. 14, 335-360.
30. Kellar K. J., Hulihan-Giblin B. A., Mulroney S. E., Lumpkin M. D. and Flores C. M. (1992) Stimulation of serotonin 1A receptors increases release of prolactin in the rat. Neuropharmacology 31, 643-647.
31. Kennett G. A., Marcou M., Dourish C. T. and Curzon G. (1987) Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: Relationship to antidepressant-like action. Eur. J. Pharmac. 138, 53-60.
32. Kohama S. G., Freesh F. and Bethea C. L. (1992) Immunocytochemical colocalization of hypothalamic progestin receptors and tyrosine hydroxylase in steroid-treated monkeys. Endocrinology 131, 509-517.
33. Kordon C., Drouva S. V., Martinez De La Escalera G. and Weiner R. I. (1994) Role of classic and peptide neuromediators in the neuroendocrine regulation of luteinizing hormone and prolactin. In The Physiology of Reproduction, 2nd Edn (eds Knobil E. and Neill J. D.), pp. 1622-1681. Raven, New York.
34. Lakoski J. M. (1988) Estrogen-induced modulation of serotonin 5-HT1A mediated responses in the dorsal raphe nucleus (DRN). Pharmacologist 30, A126.
35. Leranth C., MacLusky N. J., Brown T. J., Chen E. C, Redmond D. E. J. and Naftolin F. (1992) Transmitter content and afferent connections of estrogen-sensitive progestin receptor-containing neurons in the primate hypothalamus. Neuroendocrinology 55, 667-682.
36. Maes M., Vandewoude M., Schotte C., Maes L., Martin M. and Blockx P. (1989) Sex-linked differences in cortisol, ACTH, and prolactin responses to 5-hydroxy-tryptophan in healthy controls and minor and major depressed patients. Acta Psychiat. Scand. 80, 584-590.
37. Maes M., D'Hondt P. D., Suy E., Minner B., Vandervorst C. and Raus J. (1991) HPA-axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls. Prog. Neuropsychopharmac. Biol. Psychiat. 15, 781-790.
38. Maswood S., Stewart G. and Uphouse L. (1995) Gender and estrous cycle effects of the 5-HT1A agonist, 8-OH-DPAT, on hypothalamic serotonin. Pharmac. Biochem. Behav. 51, 807-813.
39. Meltzer H. Y., Flemming R. and Robertson A. (1983) The effect of buspirone on prolactin and growth hormone secretion in man. Archs Gen. Psychiat. 40, 1099-1102.
40. Mortola J. F. (1994) A risk-benefit appraisal of drugs used in the management of premenstrual syndrome. Drug Safety 10, 160-169.
41. Oppenheim G. (1983) Estrogen in the treatment of depression: Neuropharmacological mechanisms. Biol. Psychiat. 18, 721-725.
42. Parry B. L. (1997) Psychobiology of premenstrual dysphoric disorder. Semin. Reprod. Endocr. 15, 55-68.
43. Pazos A. and Palacious J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346, 205-230.
44. Pecins-Thompson M., Brown N. A. and Bethea C. L. (1998) Regulation of serotonin reuptake transporter mRNA expression by ovarian steroids in rhesus macaques. Molec. Brain Res. 53, 120-129.
45. Pecins-Thompson M., Brown N. A., Kohama S. G. and Bethea C. L. (1996) Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J. Neurosci. 16, 7021-7029.
46. Pecins-Thompson M. and Bethea C. L. (1997) RU 486 blocks and fluoxetine augments progesterone-induced prolactin secretion in monkeys. Neuroendocrinology 65, 335-343.
47. Sharp T., McQuade R., Bramwell S. and Hjorth S. (1993) Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo. Naunyn-schmiedeberg's Arch. Pharmac. 348, 339-346.
48. Sharp T. and Hjorth S. (1990) Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor. J. Neurosci. Meth. 34, 83-90.
49. Sherwin B. B. (1991) The psychoendocrinology of aging and female sexuality. A. Rev. Sex Res. 2, 181-198.
50. Sherwin B. B. (1996) Menopause, early aging and eldlerly women. In Psychopharmacology and Women. Sex, Gender and Hormones (eds Jensvold M. F., Halbreich U. and Hamilton J. A.), pp. 225-240. American Psychiatric Press, Washington, DC.
51. Singh A. and Lucki I. (1993) Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors. Neuropharmacology 32, 331-340.
52. Sprangers S. A., Brenner R. M. and Bethea C. L. (1989) Estrogen and progestin receptor immunocytochemistry in lactotropes versus gonadotropes of monkey pituitary cell cultures. Endocrinology 124, 1462-1470.
53. Sprangers S. A., West N. B., Brenner R. M. and Bethea C. L. (1990) Regulation and localization of estrogen and progestin receptors in the pituitary of steroid-treated monkeys. Endocrinology 126, 1133-1142.
54. Sprouse J. S. and Aghajanian G. K. (1986) ( - )-Propanolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur. J. Pharmac. 128, 295-298.
55. Starkey S. J. and Skingle M. (1994) 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphe nucleus. Neuropharmacology 33, 393-402.
56. Steiner M., Steinber S., Stewart D., Carter D., Berger C., Reid R., Grover D. and Streiner D. (1995) Fluoxetine in the treatment of premenstrual dysphoria. New Engl. J. Med. 332, 1529-1534.
57. Su T. P., Schmidt P. J., Danaceau M., Murphy D. L. and Rubinow D. R. (1997) Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. J. Clin. Endocr. Metab. 82, 1220-1228.
58. Van De Kar L. D. (1991) Neuroendocrine pharmacology of serotonergic (5-HT) neurons. A. Rev. Pharmac. Toxic. 31, 289-320.
59. VanderMaelen C. P., Matheson G. K., Wilderman R. C. and Patterson L. A. (1986) Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur. J. Pharmac. 129, 123-130.
60. Weissman M. N. and Klerman G. L. (1985) Gender and depression. Trends Neurosci. 8, 416-420.
61. Williams R. F., Gianfortoni J. G. and Hodgen G. D. (1985) Hyperprolactinemia induced by an estrogen-progesterone synergy: Quantitative and temporal effects of estrogen priming in monkeys. J. Clin. Endocr. Metab. 60, 126-132.
62. Wright D. E., Seroogy K. B., Lundgren K. H., Davis B. M. and Jennes E. (1995) Comparative localization of serotonin 1A, 1C, and 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351, 357-373.